应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NUVL Nuvalent, Inc.
盘后交易 12-16 17:34:48 EST
102.63
-2.34
-2.23%
盘后
102.63
+0.00
0.00%
16:20 EST
最高
104.71
最低
101.70
成交量
46.29万
今开
104.05
昨收
104.97
日振幅
2.87%
总市值
79.70亿
流通市值
49.13亿
总股本
7,766万
成交额
4,768万
换手率
0.97%
流通股本
4,787万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nuvalent, Inc.盘中异动 大幅拉升5.06%报112.55美元
市场透视 · 11-20
Nuvalent, Inc.盘中异动 大幅拉升5.06%报112.55美元
Nuvalent宣布FDA接受Zidesamtinib的新药申请，用于治疗已接受TKI治疗的晚期ROS1阳性NSCLC患者
美股速递 · 11-20
Nuvalent宣布FDA接受Zidesamtinib的新药申请，用于治疗已接受TKI治疗的晚期ROS1阳性NSCLC患者
全球股市概览：市场动态
投资观察 · 11-18
全球股市概览：市场动态
Nuvalent：计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据
美股速递 · 11-17
Nuvalent：计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据
Nuvalent：Neladalkib展现出良好的耐受性安全特征，剂量中断和剂量减少发生率低
美股速递 · 11-17
Nuvalent：Neladalkib展现出良好的耐受性安全特征，剂量中断和剂量减少发生率低
Nuvalent在253名ALK TKI预处理患者中的ORR为31%，估计18个月时53%的应答者仍保持反应
美股速递 · 11-17
Nuvalent在253名ALK TKI预处理患者中的ORR为31%，估计18个月时53%的应答者仍保持反应
Nuvalent公布ALK阳性晚期非小细胞肺癌TKI预处理患者的ALKOVE-1临床试验Neladalkib的关键数据时间安排
美股速递 · 11-15
Nuvalent公布ALK阳性晚期非小细胞肺癌TKI预处理患者的ALKOVE-1临床试验Neladalkib的关键数据时间安排
华尔街顶级分析师最新评级报告：美国电话电报公司评级上调
环球市场播报 · 11-12
华尔街顶级分析师最新评级报告：美国电话电报公司评级上调
Nuvalent, Inc.跌2.98% 股价跌破100美元大关
市场透视 · 10-31
Nuvalent, Inc.跌2.98% 股价跌破100美元大关
Nuvalent, Inc. - 预计将在2025年底报告Neladalkib在已接受TKI治疗的晚期ALK阳性非小细胞肺癌中的关键临床数据
美股速递 · 10-30
Nuvalent, Inc. - 预计将在2025年底报告Neladalkib在已接受TKI治疗的晚期ALK阳性非小细胞肺癌中的关键临床数据
Nuvalent强调近期管道进展，重申关键预期里程碑，并报告2025年第三季度财务业绩
美股速递 · 10-30
Nuvalent强调近期管道进展，重申关键预期里程碑，并报告2025年第三季度财务业绩
Nuvalent, Inc.盘中异动 下午盘股价大跌5.08%报92.24美元
市场透视 · 10-23
Nuvalent, Inc.盘中异动 下午盘股价大跌5.08%报92.24美元
Nuvalent, Inc.盘中异动 急速上涨5.11%
市场透视 · 10-21
Nuvalent, Inc.盘中异动 急速上涨5.11%
Nuvalent, Inc.盘中异动 下午盘股价大跌5.35%
市场透视 · 10-15
Nuvalent, Inc.盘中异动 下午盘股价大跌5.35%
Nuvalent, Inc.在2025年世界肺癌大会上公布Zidesamtinib治疗既往接受TKI治疗的晚期ROS1阳性非小细胞肺癌患者的Arros-1临床试验关键数据
美股速递 · 09-07
Nuvalent, Inc.在2025年世界肺癌大会上公布Zidesamtinib治疗既往接受TKI治疗的晚期ROS1阳性非小细胞肺癌患者的Arros-1临床试验关键数据
Nuvalent, Inc.盘中异动 股价大跌5.31%
市场透视 · 08-07
Nuvalent, Inc.盘中异动 股价大跌5.31%
Baird：维持Nuvalent评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。
金融界 · 06-25
Baird：维持Nuvalent评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。
Nuvalent, Inc.盘中异动 急速下挫5.08%报67.46美元
市场透视 · 03-11
Nuvalent, Inc.盘中异动 急速下挫5.08%报67.46美元
Nuvalent, Inc.2024财年实现净利润-2.61亿美元，同比减少107.14%
市场透视 · 03-07
Nuvalent, Inc.2024财年实现净利润-2.61亿美元，同比减少107.14%
Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元
财报速递 · 02-27
Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元
加载更多
公司概况
公司名称：
Nuvalent, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。该公司利用团队在化学和基于结构的药物设计方面的深厚专业知识，开发创新的小分子，其设计旨在克服现有疗法对临床证明的激酶靶点的限制。目前可用的激酶抑制剂面临的限制可能包括（i）激酶耐药性，或激酶靶点出现新的突变，从而能够对现有疗法产生耐药性，（ii）激酶选择性，或现有疗法可能抑制结构相似的激酶靶点并导致脱靶不良事件，以及（iii）有限的脑外显率，或该疗法治疗已经扩散或转移到大脑的疾病的能力。
发行价格：
--
{"stockData":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":102.63,"timestamp":1765918800000,"preClose":104.97,"halted":0,"volume":462924,"hourTrading":{"tag":"盘后","latestPrice":102.63,"preClose":102.63,"latestTime":"16:20 EST","volume":19907,"amount":2043055.41,"timestamp":1765920000439},"delay":0,"floatShares":47871700,"shares":77657211,"eps":-5.320026,"marketStatus":"盘后交易","change":-2.34,"latestTime":"12-16 17:34:48 EST","open":104.05,"high":104.71,"low":101.695,"amount":47677019.57172,"amplitude":0.028722,"askPrice":102.62,"askSize":2,"bidPrice":99.99,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-5.320026,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765933200000},"marketStatusCode":4,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":104.97,"preHourTrading":{"tag":"盘前","latestPrice":104.7,"preClose":104.97,"latestTime":"09:29 EST","volume":1311,"amount":137226.098484,"timestamp":1765895399020},"postHourTrading":{"tag":"盘后","latestPrice":102.63,"preClose":102.63,"latestTime":"16:20 EST","volume":19907,"amount":2043055.41,"timestamp":1765920000439},"volumeRatio":0.89495,"impliedVol":0.4028,"impliedVolPercentile":0.192},"requestUrl":"/m/hq/s/NUVL","defaultTab":"news","newsList":[{"id":"2585403198","title":"Nuvalent, Inc.盘中异动 大幅拉升5.06%报112.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585403198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585403198?lang=zh_cn&edition=full","pubTime":"2025-11-20 23:46","pubTimestamp":1763653571,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日23时46分，Nuvalent, Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报112.55美元/股，成交量20.2582万股，换手率0.26%，振幅5.72%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为1.92%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202346129775dd6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202346129775dd6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"1106074107","title":"Nuvalent宣布FDA接受Zidesamtinib的新药申请，用于治疗已接受TKI治疗的晚期ROS1阳性NSCLC患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1106074107","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106074107?lang=zh_cn&edition=full","pubTime":"2025-11-20 05:21","pubTimestamp":1763587269,"startTime":"0","endTime":"0","summary":"Nuvalent宣布FDA接受Zidesamtinib的新药申请，用于治疗已接受TKI治疗的晚期ROS1阳性NSCLC患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"1121008983","title":"全球股市概览：市场动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1121008983","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121008983?lang=zh_cn&edition=full","pubTime":"2025-11-18 07:07","pubTimestamp":1763420851,"startTime":"0","endTime":"0","summary":"最新的市场动态涵盖了股票市场。文章在道琼斯新闻社全天独家发布。现任CEO Mark Allison表示他将至少留任到九月份。与此同时，Elders正在进行寻找潜在接班人的流程。它对Elders的覆盖评级重启，给予“跑赢大盘”的评级，目标价为每股8.25澳元。Elders在周一收盘价为7.41澳元。它维持对New Hope的增持评级。销售额增长2.2%，息税折旧摊销前利润增长12%，净利润增长34%。Catapult Sports报告上半年营业利润增长56%。Brands股价上涨0.2%，至149.28美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","AAPL","LU0942090050.USD","LU0861579265.USD","LU0345769631.USD","LU0011850046.USD","LU0320765059.SGD","LU0689626769.HKD","LU0345769128.USD","LU1699723380.USD","LU2236285917.USD","LU2417539215.USD","LU1206713676.USD","LU2106854487.HKD","LU2168564149.EUR","LU1162221912.USD","LU1582986359.USD","LU2083900584.USD","IE00B19Z8X17.USD","LU0234572021.USD","LU1868837136.USD","BK4139","LU0106261372.USD","BK4533","LU2237443622.USD","LU1066053197.SGD","LU0354030511.USD","LU0149725797.USD","LU0965509010.AUD","LU0314104364.USD","LU2023250504.SGD","HK0000320223.HKD","IE00B775SV38.USD","LU1037948541.HKD","LU1804176565.USD","LU1582986433.USD","LU0265550946.USD","LU1363072403.SGD","SG9999002224.SGD","LU2360106780.USD","LU0494093205.USD","LU1066051498.USD","LU2125154935.USD","LU1674673428.USD","LU1206712785.SGD","LU0267386448.USD","BK4588","LU2237443382.USD","LU2756315664.SGD","LU0124676726.USD","LU2471134952.CNY","LU1989764748.USD","BK4127","LU1868836914.USD","IE00B19Z9505.USD","LU0528227936.USD","LU2237438978.USD","IE0004445015.USD","LU1935042991.SGD","IE0004086264.USD","IE000W1ABFV2.USD","LU0056508442.USD","BK4501","SG9999014567.USD","LU1037948897.HKD","LU0320765646.SGD","LU0786609619.USD","SG9999015341.SGD","SG9999014575.USD","LU1989772840.SGD","LU1935043536.SGD","LU0203201768.USD","LU1868837300.USD","LU1989764664.SGD","LU0109392836.USD","LU1261432733.SGD","LU0823421416.USD","LU0985320562.USD","BK4559","LU2471134796.USD","LU0265550359.USD","LU2552382215.SGD","LU0096362180.USD","LU2360032135.SGD","LU2065171311.SGD","LU1914381329.SGD","LU2191332357.HKD","LU2237443978.SGD","LU1791710400.SGD","LU1791710582.SGD","LU0965509101.SGD","LU1989772923.USD","LU2381873111.SGD","LU0289961442.SGD","LU0353189763.USD","BK4574","LU2065169927.USD","LU1074936037.SGD","LU2065170008.USD","LU1718418525.SGD","BK4581","LU0957791311.USD","LU2125154778.USD","LU2023250330.USD","IE00BJJMRX11.SGD","LU1301847155.USD","LU2543165471.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU0345768740.USD","LU0354030438.USD","LU2357305700.SGD","BK4516","IE00B1BXHZ80.USD","LU1934455194.USD","LU1852331112.SGD","LU1720051108.HKD","LU1003077747.HKD","LU0353189680.USD","LU1127390331.HKD","SG9999017495.SGD","LU0198837287.USD","IE00B775H168.HKD","BK4585","MACW.SI","LU1035775433.USD","LU2265009873.SGD","LU0345770308.USD","LU0965508806.USD","LU2111349929.HKD","LU0053666078.USD","IE00BKDWB100.SGD","LU2242650005.HKD","LU0238689110.USD","LU0949170426.SGD","LU0210533765.USD","IE00BN29S564.USD","LU0158827781.USD","LU1242518857.USD","SG9999015358.SGD","LU0444973449.USD","LU1244550494.USD","LU1551013342.USD","BK4527","BK4507","LU1235294995.USD","LU2750360641.GBP","LU0912757837.SGD","LU2896262040.SGD","LU0965509283.SGD","LU1935042215.USD","MS","LU1232071149.USD","LU2092937148.SGD","LU0557290698.USD","LU1582987597.SGD","LU2097344431.USD","LU2087621335.USD","IE00BLSP4239.USD","LU2347655156.SGD","LU2487616109.SGD","LU2271345857.HKD","LU0683600562.USD","LU1066051225.USD","LU2250418816.HKD","IE0001KFT4U8.USD","LU1496350171.SGD","IE0034235303.USD","LU0082616367.USD","LU0964807845.USD","LU1732799900.SGD","BK4534","LU0080751232.USD","LU1316542783.SGD","BK4566","BK4575","IE00BJTD4N35.SGD","LU0417517546.SGD","LU2430703251.USD","LU1267930730.SGD","IE00B3SWFQ91.USD","LU1116320737.USD","BK4504","LU2505996681.GBP","LU0289739343.SGD","LU0949170772.SGD","LU1935043023.USD","LU2242649171.HKD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","LU1582987324.SGD","LU0788109477.HKD","IE0009356076.USD","BK4505","LU0787776722.HKD","SG9999015986.USD","IE00BFSS7M15.SGD","BK4571","IE00BFSS8Q28.SGD","LU2087625088.SGD","IE00BK4W5L77.USD","BK4512","LU2403377893.USD","LU2420271590.USD","LU2168564065.EUR","LU2746668974.SGD","LU0784385170.HKD","LU2505996509.AUD","LU1868836757.USD","LU0784384876.USD","LU0314106906.USD","BK4170","SG9999014880.SGD","LU0308772762.SGD","LU0823434583.USD","LU2452424414.USD","LU0795875169.SGD","IE00BLSP4452.SGD","LU1814569148.SGD","IE000YTNTUN2.SGD","IE0004445239.USD","LU2592432038.USD","LU0061474960.USD","LU1366333091.USD","BK4515","LU0820561818.USD","BK4553","IE00BKVL7J92.USD","LU0072462426.USD","LU0545039389.USD","IE000KEQY171.SGD","LU2168564222.USD","BK4598","LU2347655073.USD","GB00BDT5M118.USD","LU0823421333.USD","LU0057025933.USD","SGXZ31699556.SGD","LU0256863902.USD","LU0724617625.USD","LU0127658192.USD","LU0456855351.SGD","LU2237443549.SGD","LU1066051811.HKD","LU0210536198.USD","LU0784383803.USD","LU0070217475.USD","IE00BN8TJ469.HKD","BK4550","IE0009G5SDU7.USD","LU2237443465.HKD","LU0868494708.USD","LU1815336760.USD","LU2092627202.USD","LU0553294199.USD","LU0345768153.USD","IE00BJJMRY28.SGD","LU0048584097.USD","LU0215105999.USD","IE00B19Z8W00.USD","LU0256863811.USD","LU2361044949.HKD","BK4539","LU0098860793.USD","LU2065171402.SGD","LU0345770993.USD","LU0109391861.USD","LU2028103732.USD","IE00BBT3K403.USD","LU1119994496.HKD","LU0784385840.USD","LU0882574139.USD","LU1244550221.USD","SG9999018865.SGD","IE00BZ1G4Q59.USD","IE00B1XK9C88.USD","LU0097036916.USD","LU0225283273.USD","LU2552382058.USD","LU0316494557.USD","LU1280957306.USD","SG9999015952.SGD","LU2237443895.HKD","LU2077746001.SGD","SG9999001424.SGD","LU2456880835.USD","LU1291159041.SGD","LU1674673691.USD","LU1839511570.USD","LU0157215616.USD","LU1823568750.SGD","LU0472753341.HKD","LU2023250843.SGD","LU0957808578.USD","HK0000306701.USD","LU0006306889.USD","LU0820562030.AUD","LU2750360997.AUD","LU0689472784.USD","IE00B5949003.HKD","LU2860962120.EUR","LU1668664300.SGD","LU1720051017.SGD","LU1548497426.USD","LU1732800096.USD","LU0079474960.USD","SG9999002232.USD","LU0943347566.SGD","LU0348723411.USD","LU2213496289.HKD","LU0889565833.HKD","LU0708995401.HKD","LU2756315318.SGD","LU1868836591.USD","SG9999014542.SGD","LU1084165304.USD","LU1571399168.USD","LU0719512351.SGD","LU2430703095.HKD","IE00BWXC8680.SGD","SG9999014914.USD","BK4592","LU0234570918.USD","LU0203202063.USD","SG9999000418.SGD","LU1366192091.USD","LU1629891620.HKD","LU1069344957.HKD","IE00B3S45H60.SGD","IE00B4YYXB79.USD","HK0000320264.USD","NUVL","LU1244550577.SGD","SG9999018857.SGD","LU1815333072.USD","IE0004091025.USD","LU1934455863.HKD","LU2063271972.USD","LU0726765562.USD","LU2247934214.USD","LU0511384066.AUD","LU0061475181.USD","LU1934455277.USD","LU0154236417.USD","LU0795875086.SGD","LU0979878070.USD","SG9999014906.USD","LU0823434740.USD","LU2471134523.USD","LU0251132253.USD","LU1642822529.SGD","LU2097344357.USD","IE00BJTD4V19.USD","LU1551013425.SGD","LU1935042488.USD","LU2054465674.USD","LU2602419157.SGD","HK0000306685.HKD","LU2361044865.SGD","IE0005OL40V9.USD","SG9999015978.USD","LU2168564495.EUR","LU0210528500.USD","LU2089284900.SGD","LU2746668461.USD","LU0323591593.USD","SG9999014898.SGD","LU0971096721.USD","LU2108987350.USD","LU2168563687.JPY","LU2458330169.SGD","LU2089283258.USD","IE00B4JS1V06.HKD","LU0096364046.USD","LU1242518931.SGD","LU2458330243.SGD","LU0476273544.USD","LU1803068979.SGD","LU0868494617.USD","LU0077335932.USD","SG9999014559.SGD","LU2430703178.SGD","BK4554","BK4532","LU2471134879.HKD","LU2286300806.USD","LU1496350502.SGD","LU2461242641.AUD","BK4576","LU0170899867.USD","LU1778281490.HKD","LU1046421795.USD","LU1974910355.USD","LU0444971666.USD","IE00BJLML261.HKD","LU0820561909.HKD","LU0738911758.USD","LU0672654240.SGD","LU1145028129.USD","LU2023251221.USD","SG9999015945.SGD","LU0069063385.USD","LU0661504455.SGD","BK4573","IE0003U64NQ7.SGD","LU1917777945.USD","LU2552382132.HKD","LU0466842654.USD","LU0106831901.USD","IE000ITXATA3.USD","LU2462157665.USD","LU2361045086.USD","LU1116320901.HKD","LU2133065610.SGD","LU0158827948.USD","BK4579","LU0640476718.USD","LU0642271901.SGD"],"gpt_icon":1},{"id":"1119995847","title":"Nuvalent：计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1119995847","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119995847?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:32","pubTimestamp":1763379171,"startTime":"0","endTime":"0","summary":"Nuvalent：计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"1100423211","title":"Nuvalent：Neladalkib展现出良好的耐受性安全特征，剂量中断和剂量减少发生率低","url":"https://stock-news.laohu8.com/highlight/detail?id=1100423211","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100423211?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:32","pubTimestamp":1763379169,"startTime":"0","endTime":"0","summary":"Nuvalent：Neladalkib展现出良好的耐受性安全特征，剂量中断和剂量减少发生率低","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"1174448154","title":"Nuvalent在253名ALK TKI预处理患者中的ORR为31%，估计18个月时53%的应答者仍保持反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1174448154","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174448154?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:32","pubTimestamp":1763379138,"startTime":"0","endTime":"0","summary":"Nuvalent在253名ALK TKI预处理患者中的ORR为31%，估计18个月时53%的应答者仍保持反应","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"1146812006","title":"Nuvalent公布ALK阳性晚期非小细胞肺癌TKI预处理患者的ALKOVE-1临床试验Neladalkib的关键数据时间安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1146812006","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146812006?lang=zh_cn&edition=full","pubTime":"2025-11-15 05:02","pubTimestamp":1763154133,"startTime":"0","endTime":"0","summary":"Nuvalent公布ALK阳性晚期非小细胞肺癌TKI预处理患者的ALKOVE-1临床试验Neladalkib的关键数据时间安排","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2582308381","title":"华尔街顶级分析师最新评级报告：美国电话电报公司评级上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2582308381","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582308381?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:05","pubTimestamp":1762959900,"startTime":"0","endTime":"0","summary":"华尔街最受关注、且能影响市场走势的研究评级报告现已汇总一处。KeyBanc 银行将美国电话电报公司的评级从 “行业权重” 上调至 “增持”，目标股价定为 30 美元。伯恩斯坦公司首次覆盖辛塔斯公司，给予 “与大盘持平” 评级，目标股价定为 200 美元。该机构认为，辛塔斯是一家 “优质成长型公司”，但当前股价已处于高位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-12/doc-infxemns6034755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ATAT","AN","KMX","BK4137","LU2506951958.HKD","LU1169589451.USD","BK4507","IE00BSNM7G36.USD","BK4534","OUT","LU1861558580.USD","CTAS","LU2506952170.USD","NTLA","QUIK","T","LU0211326839.USD","BK4550","BK4585","LU0175139822.USD","BK4556","LU1169590202.USD","CVNA","BK4142","BK4200","PGNY","LU0650527681.SGD","LU1621768206.USD","BHF","FND","NUVL","BBWI","BK4503","BK4162","BK4141","LU1621767810.EUR","GRAL","BK4214","BK4598","BK4154","LU1621768115.EUR","LU1571399168.USD","BK4234","BK4215","CSR","LU0823417653.USD","BK4548","BK4139","BK4588","BK4535"],"gpt_icon":0},{"id":"2579890894","title":"Nuvalent, Inc.跌2.98% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2579890894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579890894?lang=zh_cn&edition=full","pubTime":"2025-10-31 03:37","pubTimestamp":1761853028,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日03时37分，Nuvalent, Inc.股票出现波动，股价快速跳水2.98%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Intensity Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Intensity Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Vivosim Labs, Inc.较为活跃，换手率分别为2693.19%、2008.27%、965.04%，振幅较大的相关个股有Intensity Therapeutics, Inc.、Azitra Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为412.14%、58.30%、53.55%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031033708a47e6119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031033708a47e6119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"1105540170","title":"Nuvalent, Inc. - 预计将在2025年底报告Neladalkib在已接受TKI治疗的晚期ALK阳性非小细胞肺癌中的关键临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1105540170","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105540170?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:37","pubTimestamp":1761820632,"startTime":"0","endTime":"0","summary":"Nuvalent, Inc. - 预计将在2025年底报告Neladalkib在已接受TKI治疗的晚期ALK阳性非小细胞肺癌中的关键临床数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"1178409484","title":"Nuvalent强调近期管道进展，重申关键预期里程碑，并报告2025年第三季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1178409484","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178409484?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:31","pubTimestamp":1761820272,"startTime":"0","endTime":"0","summary":"Nuvalent强调近期管道进展，重申关键预期里程碑，并报告2025年第三季度财务业绩","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2577320626","title":"Nuvalent, Inc.盘中异动 下午盘股价大跌5.08%报92.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577320626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577320626?lang=zh_cn&edition=full","pubTime":"2025-10-23 01:13","pubTimestamp":1761153197,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日01时13分，Nuvalent, Inc.股票出现波动，股价大幅跳水5.08%。截至发稿，该股报92.24美元/股，成交量28.8741万股，换手率0.40%，振幅5.69%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011317a6c86044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011317a6c86044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2577844129","title":"Nuvalent, Inc.盘中异动 急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577844129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577844129?lang=zh_cn&edition=full","pubTime":"2025-10-21 01:57","pubTimestamp":1760983070,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日01时57分，Nuvalent, Inc.股票出现异动，股价快速上涨5.11%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Replimune Group, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alto Neuroscience, Inc.涨幅较大，Azitra Inc、Genprex, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1704.75%、1478.37%、303.29%，振幅较大的相关个股有Bio Green Med Solution Inc. 6% Cnv Pfd Usd、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alto Neuroscience, Inc.，振幅分别为140.80%、93.37%、89.80%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102101575094d43e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102101575094d43e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2575745222","title":"Nuvalent, Inc.盘中异动 下午盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575745222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575745222?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:10","pubTimestamp":1760461854,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时10分，Nuvalent, Inc.股票出现波动，股价急速下跌5.35%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2813.49%、38.90%、38.05%，振幅较大的相关个股有Pmgc Holdings Inc.、Cdt Equity Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts To Pur Com，振幅分别为55.85%、38.33%、37.50%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501105494c9207e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501105494c9207e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"1167884170","title":"Nuvalent, Inc.在2025年世界肺癌大会上公布Zidesamtinib治疗既往接受TKI治疗的晚期ROS1阳性非小细胞肺癌患者的Arros-1临床试验关键数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1167884170","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167884170?lang=zh_cn&edition=full","pubTime":"2025-09-07 16:46","pubTimestamp":1757234776,"startTime":"0","endTime":"0","summary":"Nuvalent, Inc.在2025年世界肺癌大会上公布了Zidesamtinib治疗既往接受TKI治疗的晚期ROS1阳性非小细胞肺癌患者的Arros-1临床试验关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2557656413","title":"Nuvalent, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557656413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557656413?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:27","pubTimestamp":1754576830,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时27分，Nuvalent, Inc.股票出现异动，股价快速下跌5.31%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1622.79%、119.06%、80.61%，振幅较大的相关个股有Palisade Bio, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为92.00%、39.49%、34.85%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722271194d5b5e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722271194d5b5e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2546437902","title":"Baird：维持Nuvalent评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546437902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546437902?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:23","pubTimestamp":1750857836,"startTime":"0","endTime":"0","summary":"Baird：维持Nuvalent(NUVL.US)评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625212941952b397b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625212941952b397b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"2518202206","title":"Nuvalent, Inc.盘中异动 急速下挫5.08%报67.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202206?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:13","pubTimestamp":1741634026,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时13分，Nuvalent, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报67.46美元/股，成交量71.6696万股，换手率1.00%，振幅3.74%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031346a26aa563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031346a26aa563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2517162594","title":"Nuvalent, Inc.2024财年实现净利润-2.61亿美元，同比减少107.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162594?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276864,"startTime":"0","endTime":"0","summary":"3月7日，Nuvalent, Inc.公布财报，公告显示公司2024财年净利润为-2.61亿美元，同比减少107.14%；其中营业收入为0.00美元，每股基本收益为-3.93美元。从资产负债表来看，Nuvalent, Inc.总负债71.96百万美元，其中短期债务0.00美元，资产负债比为0.16，流动比率为0.21。机构评级：截至2025年3月7日，当前有11家机构对Nuvalent, Inc.目标价做出预测，其中目标均价为113.73美元，其中最低目标价为100.00美元，最高目标价为137.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"1194057199","title":"Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194057199","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194057199?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:40","pubTimestamp":1740656431,"startTime":"0","endTime":"0","summary":"Nuvalent报告其每股季度亏损1.05美元，超出分析师普遍预期的1.08美元，比预期高出2.78%。与去年同期的每股亏损0.62美元相比，亏损增加了69.35%。以上内容来自Benzinga Earnings专栏，原文如下：Nuvalent reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.78 percent. This is a 69.35 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvalent.com","stockEarnings":[{"period":"1week","weight":-0.0269},{"period":"1month","weight":0.0878},{"period":"3month","weight":0.3401},{"period":"6month","weight":0.3898},{"period":"1year","weight":0.2085},{"period":"ytd","weight":0.341}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。该公司利用团队在化学和基于结构的药物设计方面的深厚专业知识，开发创新的小分子，其设计旨在克服现有疗法对临床证明的激酶靶点的限制。目前可用的激酶抑制剂面临的限制可能包括（i）激酶耐药性，或激酶靶点出现新的突变，从而能够对现有疗法产生耐药性，（ii）激酶选择性，或现有疗法可能抑制结构相似的激酶靶点并导致脱靶不良事件，以及（iii）有限的脑外显率，或该疗法治疗已经扩散或转移到大脑的疾病的能力。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.039512},{"month":2,"riseRate":0.75,"avgChangeRate":0.025601},{"month":3,"riseRate":0,"avgChangeRate":-0.092764},{"month":4,"riseRate":0.5,"avgChangeRate":0.024196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.006145},{"month":6,"riseRate":1,"avgChangeRate":0.177709},{"month":7,"riseRate":1,"avgChangeRate":0.08966},{"month":8,"riseRate":0.6,"avgChangeRate":0.217715},{"month":9,"riseRate":0.8,"avgChangeRate":0.02208},{"month":10,"riseRate":0.8,"avgChangeRate":0.213383},{"month":11,"riseRate":0.6,"avgChangeRate":0.048468},{"month":12,"riseRate":0.2,"avgChangeRate":-0.061254}],"exchange":"NASDAQ","name":"Nuvalent, Inc.","nameEN":"Nuvalent, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvalent, Inc.,NUVL,Nuvalent, Inc.股票,Nuvalent, Inc.股票老虎,Nuvalent, Inc.股票老虎国际,Nuvalent, Inc.行情,Nuvalent, Inc.股票行情,Nuvalent, Inc.股价,Nuvalent, Inc.股市,Nuvalent, Inc.股票价格,Nuvalent, Inc.股票交易,Nuvalent, Inc.股票购买,Nuvalent, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}